Mario Varasi
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications
Targetable Vulnerabilities in MYC-Driven B Cell Lymphomas Resistant to BCR Extinction.
Journal: Hematological oncology
Published: December 06, 2025
Targetable Vulnerabilities in MYC-Driven B Cell Lymphomas Resistant to BCR Extinction.
Journal: Hematological oncology
Published: December 06, 2025
B-cell Receptor Silencing Reveals the Origin and Dependencies of High-Grade B-cell Lymphomas with MYC and BCL2 Rearrangements.
Journal: Blood cancer discovery
Published: March 19, 2025
Structure-based design of potent and selective inhibitors of the HECT ligase NEDD4.
Journal: Communications chemistry
Published: January 23, 2025
A multiparametric screen uncovers FDA-approved small molecules that potentiate the nuclear mechano-dysfunctions in ATR-defective cells.
Journal: Scientific reports
Published: June 30, 2024
The CRL7FBXW8 Complex Controls the Mammary Stem Cell Compartment through Regulation of NUMB Levels.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: May 27, 2024
Novel selective inhibitors of macropinocytosis-dependent growth in pancreatic ductal carcinoma.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: March 07, 2024
Enrichment of DNA replication intermediates by EdU pull down.
Journal: Methods in cell biology
Published: February 15, 2024
Caloric restriction leads to druggable LSD1-dependent cancer stem cells expansion.
Journal: Nature communications
Published: August 07, 2023
Novel pyridine-containing histone deacetylase inhibitors strongly arrest proliferation, induce apoptosis and modulate miRNAs in cancer cells.
Journal: European journal of medicinal chemistry
Published: September 19, 2022
Last Updated: 09/26/2026